Jacobs Levy Equity Management
RPID icon

Jacobs Levy Equity Management’s Rapid Micro Biosystems RPID Stock Holding History

Jacobs Levy Equity Management’s Portfolio RPID Stock Details RPID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-161,400
Closed -$182K – 1052
2022
Q4 		$182K Buy
+161,400
New +$391K ﹤0.01% 913
2022
Q2 		– Sell
-94,173
Closed -$639K – 1074
2022
Q1 		$639K Buy
+94,173
New +$693K ﹤0.01% 828

Other funds holding RPID

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
KLM
Kennedy Lewis Management New York $21.9M AUM 12.46% 1-Year Est. Return
RMC
Resources Management Corp West Hartford, Connecticut $753M AUM 20.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AWGLSCP
ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jacobs Levy Equity Management's RPID Position: Q1 2023 in Review

Jacobs Levy Equity Management sold out of Rapid Micro Biosystems (RPID) in Q1 2023, closing a stake of 161,400 shares — an estimated $182K sold.

Jacobs Levy Equity Management first reported a position in RPID in Q1 2022 and held it in 2 quarters. The position peaked at $639K in Q1 2022. 31 funds tracked by Wall St. Rank hold RPID as of Q1 2023.

  • Jacobs Levy Equity Management reported no remaining Rapid Micro Biosystems position as of Q1 2023 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 161,400 Rapid Micro Biosystems shares in Q1 2023, an estimated $182K.
  • Jacobs Levy Equity Management first reported a position in Rapid Micro Biosystems in Q1 2022 and held it in 2 quarters.
  • Jacobs Levy Equity Management's Rapid Micro Biosystems position peaked at $639K in Q1 2022.
  • 31 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q1 2023.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2023, filed 15 May 2023.